세계의 단백질 엔지니어링 시장 : 규모, 점유율, 동향 분석 보고서 - 제품별, 최종 용도별, 기술별, 단백질 유형별, 지역별 전망 및 예측(2024-2031년)

The Global Protein Engineering Market size is expected to reach $7.8 billion by 2031, rising at a market growth of 16.0% CAGR during the forecast period.

Protein engineering is crucial in developing and optimizing growth factors, signaling proteins that regulate cell growth, proliferation, and differentiation. This engineering has been used to develop novel growth factors with enhanced specificity and potency. Consequently, the growth factors segment would acquire nearly 12% of the total market share by 2031. To enhance its effectiveness in promoting blood vessel formation, for instance, scientists have engineered variants of vascular endothelial growth factor (VEGF), a key regulator of angiogenesis.

By abandoning the conventional "one-size-fits-all" approach in favor of a more individualized treatment paradigm, personalized medicine is currently transforming the healthcare infrastructure. Personalized medicine harnesses the power of genomic and molecular data to guide clinical decisions. By analyzing a patient's genetic profile, healthcare providers can identify specific genetic mutations, biomarkers, and pathways involved in their disease. Therefore, with the continuous evolution of this engineering and genomic technologies, the potential for personalized medicine to revolutionize healthcare and enhance patient outcomes will inevitably expand, propelling the market's expansion. Additionally, Innovations in technologies like CRISPR, synthetic biology, and computational protein design enhance the ability to engineer proteins with desired characteristics. Synthetic biology has been used to engineer yeast and bacteria to produce complex pharmaceuticals like artemisinin, an antimalarial drug, which traditionally had a complex and costly extraction process from plants. Thus, the advancements in this engineering technologies like CRISPR, synthetic biology, and computational protein design are driving significant growth in the market.

The COVID-19 pandemic accelerated the digital transformation of the healthcare industry, leading to greater utilization of computational tools and artificial intelligence in this engineering. This digitalization brought the potential to streamline this engineering process, reduce development timelines, and enhance the efficiency of drug discovery and development efforts. The demand for engineering solutions that leverage these technologies grew as the healthcare industry embraced digital technologies. Therefore, the pandemic had an overall positive impact on the market.

However, Developing engineered proteins requires substantial investment in various areas, including advanced laboratory equipment, skilled personnel, research materials, and infrastructure. Personnel costs also contribute significantly to the engineering R&D. Recruiting and retaining skilled scientists, biotechnologists, and bioinformaticians proficient in this engineering techniques can be costly, especially in regions with high competition for talent. Hence, these factors may hamper the growth of the market.

Product Outlook

Based on product, the market is characterized into instruments, reagents, and software & services. The reagents segment procured 35% revenue share in the market in 2023. Reagents, including enzymes, antibodies, buffers, and substrates, are essential in the engineering experiments. The increasing adoption of recombinant DNA technology and protein expression systems has driven the demand for high-quality reagents, supporting the growth of this segment.

End-use Outlook

Based on end-use, the market is segmented into academic research institutes, contract research organizations (CROs), pharmaceutical & biotechnology companies. The contract research organizations (CROs) segment witnessed 38.5% revenue share in the market in 2023. CROs are vital in providing the engineering services to pharmaceutical, biotechnology, and academic research institutions, offering expertise and resources for protein design, expression, purification, and characterization.

Technology Outlook

On the basis of technology, the market is classified into rational protein design, directed evolution, hybrid approach, de novo protein design, and others. The hybrid approach segment recorded 34.2% revenue share in the market in 2023. The hybrid approach combines elements of rational protein design and directed evolution, leveraging computational modeling and experimental evolution to engineer proteins with improved or novel functions.

Protein Type Outlook

By protein type, the market is divided into insulin, monoclonal antibodies, vaccines, growth factors, colony stimulating factors, coagulation factors, interferon, and others. The insulin segment garnered 16.75% revenue share in the market in 2023. Insulin, a life-saving therapeutic protein for diabetic patients, exemplifies the crucial role of this engineering in chronic disease management. The engineering advancements have produced a variety of insulin formulations that more closely resemble the body's endogenous insulin secretion.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment garnered 39.8% revenue share in the market in 2023. The region's strong biotechnology and pharmaceutical sectors, in addition to substantial investments in the engineering research and development, are factors contributing to this.

List of Key Companies Profiled

• Agilent Technologies, Inc.
• Bruker Corporation
• Thermo Fisher Scientific, Inc.
• Waters Corporation
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• Danaher Corporation
• Genscript Biotech Corporation
• Amgen, Inc.
• Promega Corporation

Global Protein Engineering Market Report Segmentation

By Product

• Instruments
• Reagents
• Software & Services

By End-use

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic Research Institutes

By Technology

• Rational Protein Design
• Hybrid Approach
• Directed Evolution
• De Novo Protein Design
• Others

By Protein Type

• Monoclonal Antibodies
• Insulin
• Vaccines
• Growth Factors
• Interferon
• Colony Stimulating Factors
• Coagulation Factors
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Protein Engineering Market, by Product
  • 1.4.2 Global Protein Engineering Market, by End-use
  • 1.4.3 Global Protein Engineering Market, by Technology
  • 1.4.4 Global Protein Engineering Market, by Protein Type
  • 1.4.5 Global Protein Engineering Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
  • 3.2.3 Market Opportunities
  • 3.2.4 Market Challenges
• 3.3 Porter Five Forces Analysis

Chapter 4. Global Protein Engineering Market by Product

• 4.1 Global Instruments Market by Region
• 4.2 Global Reagents Market by Region
• 4.3 Global Software & Services Market by Region

Chapter 5. Global Protein Engineering Market by End-use

• 5.1 Global Pharmaceutical & Biotechnology Companies Market by Region
• 5.2 Global Contract Research Organizations (CROs) Market by Region
• 5.3 Global Academic Research Institutes Market by Region

Chapter 6. Global Protein Engineering Market by Technology

• 6.1 Global Rational Protein Design Market by Region
• 6.2 Global Hybrid Approach Market by Region
• 6.3 Global Directed Evolution Market by Region
• 6.4 Global De Novo Protein Design Market by Region
• 6.5 Global Others Market by Region

Chapter 7. Global Protein Engineering Market by Protein Type

• 7.1 Global Monoclonal Antibodies Market by Region
• 7.2 Global Insulin Market by Region
• 7.3 Global Vaccines Market by Region
• 7.4 Global Growth Factors Market by Region
• 7.5 Global Interferon Market by Region
• 7.6 Global Colony Stimulating Factors Market by Region
• 7.7 Global Coagulation Factors Market by Region
• 7.8 Global Others Market by Region

Chapter 8. Global Protein Engineering Market by Region

• 8.1 North America Protein Engineering Market
  • 8.1.1 North America Protein Engineering Market by Product
    • 8.1.1.1 North America Instruments Market by Country
    • 8.1.1.2 North America Reagents Market by Country
    • 8.1.1.3 North America Software & Services Market by Country
  • 8.1.2 North America Protein Engineering Market by End-use
    • 8.1.2.1 North America Pharmaceutical & Biotechnology Companies Market by Country
    • 8.1.2.2 North America Contract Research Organizations (CROs) Market by Country
    • 8.1.2.3 North America Academic Research Institutes Market by Country
  • 8.1.3 North America Protein Engineering Market by Technology
    • 8.1.3.1 North America Rational Protein Design Market by Country
    • 8.1.3.2 North America Hybrid Approach Market by Country
    • 8.1.3.3 North America Directed Evolution Market by Country
    • 8.1.3.4 North America De Novo Protein Design Market by Country
    • 8.1.3.5 North America Others Market by Country
  • 8.1.4 North America Protein Engineering Market by Protein Type
    • 8.1.4.1 North America Monoclonal Antibodies Market by Country
    • 8.1.4.2 North America Insulin Market by Country
    • 8.1.4.3 North America Vaccines Market by Country
    • 8.1.4.4 North America Growth Factors Market by Country
    • 8.1.4.5 North America Interferon Market by Country
    • 8.1.4.6 North America Colony Stimulating Factors Market by Country
    • 8.1.4.7 North America Coagulation Factors Market by Country
    • 8.1.4.8 North America Others Market by Country
  • 8.1.5 North America Protein Engineering Market by Country
    • 8.1.5.1 US Protein Engineering Market
      • 8.1.5.1.1 US Protein Engineering Market by Product
      • 8.1.5.1.2 US Protein Engineering Market by End-use
      • 8.1.5.1.3 US Protein Engineering Market by Technology
      • 8.1.5.1.4 US Protein Engineering Market by Protein Type
    • 8.1.5.2 Canada Protein Engineering Market
      • 8.1.5.2.1 Canada Protein Engineering Market by Product
      • 8.1.5.2.2 Canada Protein Engineering Market by End-use
      • 8.1.5.2.3 Canada Protein Engineering Market by Technology
      • 8.1.5.2.4 Canada Protein Engineering Market by Protein Type
    • 8.1.5.3 Mexico Protein Engineering Market
      • 8.1.5.3.1 Mexico Protein Engineering Market by Product
      • 8.1.5.3.2 Mexico Protein Engineering Market by End-use
      • 8.1.5.3.3 Mexico Protein Engineering Market by Technology
      • 8.1.5.3.4 Mexico Protein Engineering Market by Protein Type
    • 8.1.5.4 Rest of North America Protein Engineering Market
      • 8.1.5.4.1 Rest of North America Protein Engineering Market by Product
      • 8.1.5.4.2 Rest of North America Protein Engineering Market by End-use
      • 8.1.5.4.3 Rest of North America Protein Engineering Market by Technology
      • 8.1.5.4.4 Rest of North America Protein Engineering Market by Protein Type
• 8.2 Europe Protein Engineering Market
  • 8.2.1 Europe Protein Engineering Market by Product
    • 8.2.1.1 Europe Instruments Market by Country
    • 8.2.1.2 Europe Reagents Market by Country
    • 8.2.1.3 Europe Software & Services Market by Country
  • 8.2.2 Europe Protein Engineering Market by End-use
    • 8.2.2.1 Europe Pharmaceutical & Biotechnology Companies Market by Country
    • 8.2.2.2 Europe Contract Research Organizations (CROs) Market by Country
    • 8.2.2.3 Europe Academic Research Institutes Market by Country
  • 8.2.3 Europe Protein Engineering Market by Technology
    • 8.2.3.1 Europe Rational Protein Design Market by Country
    • 8.2.3.2 Europe Hybrid Approach Market by Country
    • 8.2.3.3 Europe Directed Evolution Market by Country
    • 8.2.3.4 Europe De Novo Protein Design Market by Country
    • 8.2.3.5 Europe Others Market by Country
  • 8.2.4 Europe Protein Engineering Market by Protein Type
    • 8.2.4.1 Europe Monoclonal Antibodies Market by Country
    • 8.2.4.2 Europe Insulin Market by Country
    • 8.2.4.3 Europe Vaccines Market by Country
    • 8.2.4.4 Europe Growth Factors Market by Country
    • 8.2.4.5 Europe Interferon Market by Country
    • 8.2.4.6 Europe Colony Stimulating Factors Market by Country
    • 8.2.4.7 Europe Coagulation Factors Market by Country
    • 8.2.4.8 Europe Others Market by Country
  • 8.2.5 Europe Protein Engineering Market by Country
    • 8.2.5.1 Germany Protein Engineering Market
      • 8.2.5.1.1 Germany Protein Engineering Market by Product
      • 8.2.5.1.2 Germany Protein Engineering Market by End-use
      • 8.2.5.1.3 Germany Protein Engineering Market by Technology
      • 8.2.5.1.4 Germany Protein Engineering Market by Protein Type
    • 8.2.5.2 UK Protein Engineering Market
      • 8.2.5.2.1 UK Protein Engineering Market by Product
      • 8.2.5.2.2 UK Protein Engineering Market by End-use
      • 8.2.5.2.3 UK Protein Engineering Market by Technology
      • 8.2.5.2.4 UK Protein Engineering Market by Protein Type
    • 8.2.5.3 France Protein Engineering Market
      • 8.2.5.3.1 France Protein Engineering Market by Product
      • 8.2.5.3.2 France Protein Engineering Market by End-use
      • 8.2.5.3.3 France Protein Engineering Market by Technology
      • 8.2.5.3.4 France Protein Engineering Market by Protein Type
    • 8.2.5.4 Russia Protein Engineering Market
      • 8.2.5.4.1 Russia Protein Engineering Market by Product
      • 8.2.5.4.2 Russia Protein Engineering Market by End-use
      • 8.2.5.4.3 Russia Protein Engineering Market by Technology
      • 8.2.5.4.4 Russia Protein Engineering Market by Protein Type
    • 8.2.5.5 Spain Protein Engineering Market
      • 8.2.5.5.1 Spain Protein Engineering Market by Product
      • 8.2.5.5.2 Spain Protein Engineering Market by End-use
      • 8.2.5.5.3 Spain Protein Engineering Market by Technology
      • 8.2.5.5.4 Spain Protein Engineering Market by Protein Type
    • 8.2.5.6 Italy Protein Engineering Market
      • 8.2.5.6.1 Italy Protein Engineering Market by Product
      • 8.2.5.6.2 Italy Protein Engineering Market by End-use
      • 8.2.5.6.3 Italy Protein Engineering Market by Technology
      • 8.2.5.6.4 Italy Protein Engineering Market by Protein Type
    • 8.2.5.7 Rest of Europe Protein Engineering Market
      • 8.2.5.7.1 Rest of Europe Protein Engineering Market by Product
      • 8.2.5.7.2 Rest of Europe Protein Engineering Market by End-use
      • 8.2.5.7.3 Rest of Europe Protein Engineering Market by Technology
      • 8.2.5.7.4 Rest of Europe Protein Engineering Market by Protein Type
• 8.3 Asia Pacific Protein Engineering Market
  • 8.3.1 Asia Pacific Protein Engineering Market by Product
    • 8.3.1.1 Asia Pacific Instruments Market by Country
    • 8.3.1.2 Asia Pacific Reagents Market by Country
    • 8.3.1.3 Asia Pacific Software & Services Market by Country
  • 8.3.2 Asia Pacific Protein Engineering Market by End-use
    • 8.3.2.1 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country
    • 8.3.2.2 Asia Pacific Contract Research Organizations (CROs) Market by Country
    • 8.3.2.3 Asia Pacific Academic Research Institutes Market by Country
  • 8.3.3 Asia Pacific Protein Engineering Market by Technology
    • 8.3.3.1 Asia Pacific Rational Protein Design Market by Country
    • 8.3.3.2 Asia Pacific Hybrid Approach Market by Country
    • 8.3.3.3 Asia Pacific Directed Evolution Market by Country
    • 8.3.3.4 Asia Pacific De Novo Protein Design Market by Country
    • 8.3.3.5 Asia Pacific Others Market by Country
  • 8.3.4 Asia Pacific Protein Engineering Market by Protein Type
    • 8.3.4.1 Asia Pacific Monoclonal Antibodies Market by Country
    • 8.3.4.2 Asia Pacific Insulin Market by Country
    • 8.3.4.3 Asia Pacific Vaccines Market by Country
    • 8.3.4.4 Asia Pacific Growth Factors Market by Country
    • 8.3.4.5 Asia Pacific Interferon Market by Country
    • 8.3.4.6 Asia Pacific Colony Stimulating Factors Market by Country
    • 8.3.4.7 Asia Pacific Coagulation Factors Market by Country
    • 8.3.4.8 Asia Pacific Others Market by Country
  • 8.3.5 Asia Pacific Protein Engineering Market by Country
    • 8.3.5.1 China Protein Engineering Market
      • 8.3.5.1.1 China Protein Engineering Market by Product
      • 8.3.5.1.2 China Protein Engineering Market by End-use
      • 8.3.5.1.3 China Protein Engineering Market by Technology
      • 8.3.5.1.4 China Protein Engineering Market by Protein Type
    • 8.3.5.2 Japan Protein Engineering Market
      • 8.3.5.2.1 Japan Protein Engineering Market by Product
      • 8.3.5.2.2 Japan Protein Engineering Market by End-use
      • 8.3.5.2.3 Japan Protein Engineering Market by Technology
      • 8.3.5.2.4 Japan Protein Engineering Market by Protein Type
    • 8.3.5.3 India Protein Engineering Market
      • 8.3.5.3.1 India Protein Engineering Market by Product
      • 8.3.5.3.2 India Protein Engineering Market by End-use
      • 8.3.5.3.3 India Protein Engineering Market by Technology
      • 8.3.5.3.4 India Protein Engineering Market by Protein Type
    • 8.3.5.4 South Korea Protein Engineering Market
      • 8.3.5.4.1 South Korea Protein Engineering Market by Product
      • 8.3.5.4.2 South Korea Protein Engineering Market by End-use
      • 8.3.5.4.3 South Korea Protein Engineering Market by Technology
      • 8.3.5.4.4 South Korea Protein Engineering Market by Protein Type
    • 8.3.5.5 Singapore Protein Engineering Market
      • 8.3.5.5.1 Singapore Protein Engineering Market by Product
      • 8.3.5.5.2 Singapore Protein Engineering Market by End-use
      • 8.3.5.5.3 Singapore Protein Engineering Market by Technology
      • 8.3.5.5.4 Singapore Protein Engineering Market by Protein Type
    • 8.3.5.6 Malaysia Protein Engineering Market
      • 8.3.5.6.1 Malaysia Protein Engineering Market by Product
      • 8.3.5.6.2 Malaysia Protein Engineering Market by End-use
      • 8.3.5.6.3 Malaysia Protein Engineering Market by Technology
      • 8.3.5.6.4 Malaysia Protein Engineering Market by Protein Type
    • 8.3.5.7 Rest of Asia Pacific Protein Engineering Market
      • 8.3.5.7.1 Rest of Asia Pacific Protein Engineering Market by Product
      • 8.3.5.7.2 Rest of Asia Pacific Protein Engineering Market by End-use
      • 8.3.5.7.3 Rest of Asia Pacific Protein Engineering Market by Technology
      • 8.3.5.7.4 Rest of Asia Pacific Protein Engineering Market by Protein Type
• 8.4 LAMEA Protein Engineering Market
  • 8.4.1 LAMEA Protein Engineering Market by Product
    • 8.4.1.1 LAMEA Instruments Market by Country
    • 8.4.1.2 LAMEA Reagents Market by Country
    • 8.4.1.3 LAMEA Software & Services Market by Country
  • 8.4.2 LAMEA Protein Engineering Market by End-use
    • 8.4.2.1 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
    • 8.4.2.2 LAMEA Contract Research Organizations (CROs) Market by Country
    • 8.4.2.3 LAMEA Academic Research Institutes Market by Country
  • 8.4.3 LAMEA Protein Engineering Market by Technology
    • 8.4.3.1 LAMEA Rational Protein Design Market by Country
    • 8.4.3.2 LAMEA Hybrid Approach Market by Country
    • 8.4.3.3 LAMEA Directed Evolution Market by Country
    • 8.4.3.4 LAMEA De Novo Protein Design Market by Country
    • 8.4.3.5 LAMEA Others Market by Country
  • 8.4.4 LAMEA Protein Engineering Market by Protein Type
    • 8.4.4.1 LAMEA Monoclonal Antibodies Market by Country
    • 8.4.4.2 LAMEA Insulin Market by Country
    • 8.4.4.3 LAMEA Vaccines Market by Country
    • 8.4.4.4 LAMEA Growth Factors Market by Country
    • 8.4.4.5 LAMEA Interferon Market by Country
    • 8.4.4.6 LAMEA Colony Stimulating Factors Market by Country
    • 8.4.4.7 LAMEA Coagulation Factors Market by Country
    • 8.4.4.8 LAMEA Others Market by Country
  • 8.4.5 LAMEA Protein Engineering Market by Country
    • 8.4.5.1 Brazil Protein Engineering Market
      • 8.4.5.1.1 Brazil Protein Engineering Market by Product
      • 8.4.5.1.2 Brazil Protein Engineering Market by End-use
      • 8.4.5.1.3 Brazil Protein Engineering Market by Technology
      • 8.4.5.1.4 Brazil Protein Engineering Market by Protein Type
    • 8.4.5.2 Argentina Protein Engineering Market
      • 8.4.5.2.1 Argentina Protein Engineering Market by Product
      • 8.4.5.2.2 Argentina Protein Engineering Market by End-use
      • 8.4.5.2.3 Argentina Protein Engineering Market by Technology
      • 8.4.5.2.4 Argentina Protein Engineering Market by Protein Type
    • 8.4.5.3 UAE Protein Engineering Market
      • 8.4.5.3.1 UAE Protein Engineering Market by Product
      • 8.4.5.3.2 UAE Protein Engineering Market by End-use
      • 8.4.5.3.3 UAE Protein Engineering Market by Technology
      • 8.4.5.3.4 UAE Protein Engineering Market by Protein Type
    • 8.4.5.4 Saudi Arabia Protein Engineering Market
      • 8.4.5.4.1 Saudi Arabia Protein Engineering Market by Product
      • 8.4.5.4.2 Saudi Arabia Protein Engineering Market by End-use
      • 8.4.5.4.3 Saudi Arabia Protein Engineering Market by Technology
      • 8.4.5.4.4 Saudi Arabia Protein Engineering Market by Protein Type
    • 8.4.5.5 South Africa Protein Engineering Market
      • 8.4.5.5.1 South Africa Protein Engineering Market by Product
      • 8.4.5.5.2 South Africa Protein Engineering Market by End-use
      • 8.4.5.5.3 South Africa Protein Engineering Market by Technology
      • 8.4.5.5.4 South Africa Protein Engineering Market by Protein Type
    • 8.4.5.6 Nigeria Protein Engineering Market
      • 8.4.5.6.1 Nigeria Protein Engineering Market by Product
      • 8.4.5.6.2 Nigeria Protein Engineering Market by End-use
      • 8.4.5.6.3 Nigeria Protein Engineering Market by Technology
      • 8.4.5.6.4 Nigeria Protein Engineering Market by Protein Type
    • 8.4.5.7 Rest of LAMEA Protein Engineering Market
      • 8.4.5.7.1 Rest of LAMEA Protein Engineering Market by Product
      • 8.4.5.7.2 Rest of LAMEA Protein Engineering Market by End-use
      • 8.4.5.7.3 Rest of LAMEA Protein Engineering Market by Technology
      • 8.4.5.7.4 Rest of LAMEA Protein Engineering Market by Protein Type

Chapter 9. Company Profiles

• 9.1 Agilent Technologies, Inc.
  • 9.1.1 Company Overview
  • 9.1.2 Financial Analysis
  • 9.1.3 Segmental and Regional Analysis
  • 9.1.4 Research & Development Expense
  • 9.1.5 SWOT Analysis
• 9.2 Bruker Corporation
  • 9.2.1 Company Overview
  • 9.2.2 Financial Analysis
  • 9.2.3 Segmental and Regional Analysis
  • 9.2.4 Research & Development Expense
  • 9.2.5 Recent strategies and developments:
    • 9.2.5.1 Acquisition and Mergers:
  • 9.2.6 SWOT Analysis
• 9.3 Thermo Fisher Scientific, Inc.
  • 9.3.1 Company Overview
  • 9.3.2 Financial Analysis
  • 9.3.3 Segmental and Regional Analysis
  • 9.3.4 Research & Development Expenses
  • 9.3.5 Recent strategies and developments:
    • 9.3.5.1 Partnerships, Collaborations, and Agreements:
    • 9.3.5.2 Acquisition and Mergers:
  • 9.3.6 SWOT Analysis
• 9.4 Waters Corporation
  • 9.4.1 Company Overview
  • 9.4.2 Financial Analysis
  • 9.4.3 Segmental and Regional Analysis
  • 9.4.4 Research & Development Expense
  • 9.4.5 SWOT Analysis
• 9.5 Bio-Rad laboratories, Inc.
  • 9.5.1 Company Overview
  • 9.5.2 Financial Analysis
  • 9.5.3 Segmental and Regional Analysis
  • 9.5.4 Research & Development Expenses
  • 9.5.5 SWOT Analysis
• 9.6 Merck KGaA
  • 9.6.1 Company Overview
  • 9.6.2 Financial Analysis
  • 9.6.3 Segmental and Regional Analysis
  • 9.6.4 Research & Development Expense
  • 9.6.5 SWOT Analysis
• 9.7 Danaher Corporation
  • 9.7.1 Company Overview
  • 9.7.2 Financial Analysis
  • 9.7.3 Segmental and Regional Analysis
  • 9.7.4 Research & Development Expense
  • 9.7.5 Recent strategies and developments:
    • 9.7.5.1 Acquisition and Mergers:
  • 9.7.6 SWOT Analysis
• 9.8 Genscript Biotech Corporation
  • 9.8.1 Company Overview
  • 9.8.2 Financial Analysis
  • 9.8.3 Regional & Segmental Analysis
  • 9.8.4 Research & Development Expenses
  • 9.8.5 SWOT Analysis
• 9.9 Amgen, Inc.
  • 9.9.1 Company Overview
  • 9.9.2 Financial Analysis
  • 9.9.3 Regional Analysis
  • 9.9.4 Research & Development Expenses
  • 9.9.5 SWOT Analysis
• 9.10. Promega Corporation
  • 9.10.1 Company Overview
  • 9.10.2 SWOT Analysis

Chapter 10. Winning Imperatives for Protein Engineering Market